Senior insider sale
Chief Financial Officer at NEUROCRINE BIOSCIENCES INC — senior position signals high conviction
$361.0K
2.31K shares
What this filing means
ABERNETHY MATT plans to sell 2.31K shares of NEUROCRINE BIOSCIENCES INC valued at approximately $361.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/14/2026ACC: 0001950047-26-009441
Officer· Chief Financial Officer
Since Mar 2026
2.31K
Shares to sell
$361.0K
Approx. market value
2.31K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Performance Stock Units
N/A
9/14/2026
2.31KTotal acquired2.31K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/14/2026 | Performance Stock Units N/A | 2.31K | — |
| Total | 2.31K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.31K
Market value
$361.0K
9/14/2026
Total
Units
2.31K
Value
$361.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/14/2026 | 2.31K | $361.0K | NASDAQ | Planned |
| Total | 2.31K | $361.0K | ||